Search bioRxiv⌕ Search

Biology subjects

van Wolfswinkel, M.

Publications and source records attributed to van Wolfswinkel, M..

2 recordsLinked to original sources

Inflammation-driven cellular selection impacts X-linked mosaicism in the epidermis

In eutherian females, the choice of which X chromosome gets embryonically inactivated is thought to be random. Somatic tissues are thus assumed to comprise cells with a 50:50 ratio of maternal:paternal X active. However, a phenomenon known as X-skewing has been observed, wherein tissue composition shifts to be dominated by cells expressing one X or the other. On a gross level, such X-skewing is phenotypically silent except in the case where one X-chromosome carries a disease mutation. Here, by leveraging a mouse model of an X-linked disease called Incontinentia Pigmenti, caused by heterozygous mutations in the NF-kB effector, Nemo, we explore how X-linked cellular dynamics shape progenitor biology in the epidermis. Lineage tracing with X-linked reporters shows that at birth, the epidermis is unexpectedly skewed toward mutant cells. Within a week, as inflammation emerges, these dynamics reverse leaving surviving animals with almost entirely wild-type epithelium. The shift is driven by loss rather than growth since mutant cells adopt an aberrant fate and die at higher rates than their wild-type neighbours; proliferation rises in both populations. Notably, wild-type proliferation scales with local tissue composition, suggesting these cells calibrate their response to the extent of the mutant burden to compensate appropriately for tissue loss. Depleting macrophages, the principal TNF- source, attenuates inflammation, mutant cell death and ultimately is expected to preserve the mutant population. Altogether, our results identify inflammation as a selective force capable of resolving deleterious mosaicism, not only in the context of an X-linked disease, but within any dynamic, clonally heterogeneous epithelium.

cell biology↗

Mtb specific HLA-E restricted T cells are induced during Mtb infection but not after BCG administration in non-human primates and humans

Novel vaccines targeting the worlds deadliest pathogen Mycobacterium tuberculosis (Mtb) are urgently needed as the efficacy of the Bacillus Calmette-Guerin (BCG) vaccine in its current use is limited. HLA-E is a virtually monomorphic unconventional antigen presentation molecule and HLA-E restricted Mtb specific CD8+ T cells can control intracellular Mtb growth, making HLA-E a promising vaccine target for Mtb. In this study, we evaluated the frequency and phenotype of HLA-E restricted Mtb specific CD4+/CD8+ T cells in the circulation and bronchoalveolar lavage fluid of two independent non-human primate (NHP) studies and from humans receiving BCG either intradermally or mucosally. BCG vaccination followed by Mtb challenge in NHPs did not affect the frequency of circulating and local HLA-E/Mtb CD4+ and CD8+ T cells, and we saw the same in humans receiving BCG. HLA-E/Mtb T cell frequencies were significantly increased after Mtb challenge in unvaccinated NHPs, which was correlated with higher TB pathology. Together, HLA-E/Mtb restricted T cells are minimally induced by BCG in humans and rhesus macaques (RMs) but can be elicited after Mtb infection in unvaccinated RMs. These results give new insights into targeting HLA-E as a potential immune mechanism against TB.

immunology↗